COMMUNIQUÉS West-GlobeNewswire

Dogecoin Cash Inc. (OTCQB: CBDS) Announces Symbol Change to DOGP, Planting Its Flag in the Memeosphere
10/06/2025
MESQUITE, NV, June 10, 2025 (GLOBE NEWSWIRE) -- Dogecoin Cash Inc. (OTCQB: CBDS), a publicly traded company operating at the intersection of digital assets and public equity markets, announced today that it has received [...]
XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology
10/06/2025
Freising, Germany, June 10, 2025 — XL-protein GmbH, a pioneer in the area of biopolymers for pharmacokinetic optimization, announced today that it has entered into a worldwide License, Development and Commercialization [...]
HepaRegeniX Doses First Patient in Phase Ib Trial with Small Molecule Inhibitor HRX-215 to Promote Liver Regeneration
10/06/2025
Tuebingen, Germany, June 10, 2025 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver disease, today announced that the first patient has been dosed in [...]
Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site
10/06/2025
UHealth — University of Miami Health System and the University of Miami Miller School of Medicine provide world-class research and renowned clinical expertise in spine surgery CLARITY is a prospective, randomized [...]
Boehringer Ingelheim and Eko Health Inc. enter digital health collaboration to improve heart murmur detection in dogs
10/06/2025
A novel canine-specific detection algorithm is designed to improve early identification of heart disease and expand access to life-extending cardiac care for dogs Ingelheim, Germany, and San Francisco, Calif., June 10, [...]
Apothecare and FIKA Cannabis Partner to Deliver Pharmacist-Led Cannabis Consultations
10/06/2025
TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Apothecare, Canada’s leading pharmacist-led cannabis consultation service, has partnered with FIKA Cannabis, one of the country’s fastest-growing lifestyle cannabis retailers, [...]
Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs
10/06/2025
Nation’s first CME-accredited course for APPs on clinical application of diagnostic biomarkers in Lung Nodule and Lung Cancer patient programs LOUISVILLE, Colo., June 10, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq [...]
Pharvaris Announces Annual Meeting of Shareholders
10/06/2025
ZUG, Switzerland, June 10, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living [...]
Nusano Stable Isotope Program Enriches Gadolinium-160 to 99.2% Purity
10/06/2025
Domestic stable isotope program key to stabilizing supply chains, enabling innovation WEST VALLEY CITY, Utah, June 10, 2025 (GLOBE NEWSWIRE) -- Nusano today announced it has successfully enriched gadolinium-160 (Gd-160 [...]
Tonix Pharmaceuticals Announces Presentation at the 2025 BIO International Convention
10/06/2025
CHATHAM, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biotechnology company with marketed products and a pipeline of development [...]
Quell Therapeutics Achieves Key Milestone in its CAR-Treg Cell Therapy Program for Inflammatory Bowel Disease
10/06/2025
Quell Therapeutics Achieves Key Milestone in its CAR-Treg Cell Therapy Program for Inflammatory Bowel Disease AstraZeneca exercises option to license the first candidate from the IBD joint research program for further [...]
Axsome Therapeutics Announces Availability of SYMBRAVO® (meloxicam and rizatriptan) for the Acute Treatment of Migraine with or without Aura in Adults
10/06/2025
SYMBRAVO represents a novel multi-mechanistic approach to treating migraine that addresses multiple pathways underlying a migraine attack SYMBRAVO On My Side offers comprehensive patient support services including [...]
e Sono and POCUS Certification Academy Launch Ultrasound Proficiency On-Demand Bundles for Key Clinical and Specialty Certifications
10/06/2025
Case-based online ultrasound simulation provides a streamlined path to earning trusted credentials and improving patient care globally HAMBURG, Germany and ROCKVILLE, Md., June 10, 2025 (GLOBE NEWSWIRE) -- e Sono (by 3B [...]
Manitoba Harvest and Whole Foods Market Collaborate to Launch New Protein-Packed, Hemp+ Superfood Smoothie Boosters
10/06/2025
Global Superseed Leader, Manitoba Harvest, Expands their Wellness Lineup with Smoothie Blends for Enhanced Nutrition Plus Energy, Mood and Immune Support NEW YORK and WINNIPEG, Manitoba, June 10, 2025 (GLOBE NEWSWIRE [...]
MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement
10/06/2025
MacroGenics received $70 million upfront cash payment from Sagard Healthcare Partners (Sagard) MacroGenics’ cash runway extended through first half of 2027 ROCKVILLE, MD, June 10, 2025 (GLOBE NEWSWIRE) -- MacroGenics, [...]
Gyre Therapeutics Announces First Dosing in Phase 1 Trial of F230 for Pulmonary Arterial Hypertension in China
10/06/2025
SAN DIEGO, June 10, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems [...]
Monte Rosa Therapeutics Announces FDA Clearance of IND Application for MRT-8102, a NEK7-Directed Molecular Glue Degrader for the Treatment of Multiple Inflammatory Diseases
10/06/2025
MRT-8102, a highly selective NEK7-directed molecular glue degrader (MGD) developed to treat inflammatory conditions linked to NLRP3, IL-1β, and IL-6 dysregulation, expands Monte Rosa’s clinical I&I portfolio Potency [...]
Metsera to Present at Goldman Sachs 46th Annual Global Healthcare Conference
10/06/2025
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) (“Metsera” or the “Company”), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic [...]
Voyager to Present at H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
10/06/2025
LEXINGTON, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced Alfred W. Sandrock [...]

Pages